Donna, from the United States, shares her journey with multiple sclerosis (MS), which she was diagnosed with in 1992 at the Mayo Clinic in Florida. Initially, she experienced symptoms like fatigue and tingling sensations, but it took time to identify the issue. After trying conventional MS medications and feeling worse, she decided to stop them and manage her condition independently.

Her husband learned about low-dose Naltrexone (LDN) through an investment opportunity for its FDA approval. Skeptical at first, Donna reluctantly started taking LDN and experienced significant improvement in her condition after three months, feeling more energized and motivated. They sought a doctor who could prescribe LDN and found a compounding pharmacy that supplied it.

After 27 years of LDN use, Donna noticed that skipping the medication led to a return of some symptoms, though they remained manageable. She continues to lead an active life, having run a nonprofit scholarship organization for 15 years, and credits LDN for her well-being despite occasional relapses. Now nearing 74, she remains busy and resilient.